1.The effect of the method of delivery on the serum level of prolactin and cortisol.
Mi Ja LEE ; Hang Mi KIM ; Young Ju KIM ; Kyung Soon LEE ; Han Ki YU ; Bock Hi WOO
Korean Journal of Obstetrics and Gynecology 1993;36(7):2590-2600
No abstract available.
Hydrocortisone*
;
Prolactin*
2.The Role of Gamma Knife Radiosurgery for Prolactin Secreting Pituitary Adenomas.
Jin Woo HUR ; Young Jin LIM ; Won LEEM ; Jae Young YANG ; Jun Seok KOH ; Tae Sung KIM ; Bong Arm RHEE ; Gook Ki KIM
Journal of Korean Neurosurgical Society 2000;29(3):336-344
No abstract available.
Prolactin*
;
Prolactinoma*
;
Radiosurgery*
3.Effect of prolactin on aldosterone secretion in humans.
Yun Ah SUNG ; Seong Yeon KIM ; Bo Youn CHO ; Hong Kyu LEE ; Chang Soon KOH ; Hun Ki MIN ; Seung Keun OH
Journal of Korean Society of Endocrinology 1992;7(2):136-142
No abstract available.
Aldosterone*
;
Humans*
;
Prolactin*
5.Effects of methysergide(serotonin antagonist) on serum prolactin response after electroconvulsive therapy.
Kwang Soo KIM ; Won Myong BAHK ; Soo Jung LEE ; Jin Hee HAN ; Tae Yul LEW ; Seung Kyu BANG
Journal of Korean Neuropsychiatric Association 1991;30(2):289-295
No abstract available.
Electroconvulsive Therapy*
;
Prolactin*
6.Effects of synthetic estrogen on the biosynthesis of testosterone, LH, and prolactin.
Sung Dong LEE ; Hyuck JUNG ; Ha Jong JANG
Korean Journal of Obstetrics and Gynecology 1991;34(12):1691-1699
No abstract available.
Estrogens*
;
Prolactin*
;
Testosterone*
7.Calcified Pituitary Adenomas.
Se Hyuck PARK ; Hyoung Chun PARK ; Sun Ho KIM ; Kyu Sung LEE ; Sang Kun PARK ; Sang Sup CHUNG ; Kyu Chang LEE
Journal of Korean Neurosurgical Society 1984;13(4):749-752
Two cases of calcified pituitary adenoma are reported, which comprise 2.44% among a surgical series of 82 pituitary adenomas. Both patients had very high serum prolactin level, which suggested the possibility of hormonal influence in formation of the calcification. The tumors were removed by a subfrontal approach to prevent and reduce possible damage to the surrounding structures.
Humans
;
Pituitary Neoplasms*
;
Prolactin
8.Serum Prolactin and Cardiac Remodeling in Subjects with Prediabetes.
Diabetes & Metabolism Journal 2017;41(3):168-169
No abstract available.
Prediabetic State*
;
Prolactin*
9.Epidemiologic profile and clinical outcomes of adult patients with prolactinoma at the Philippine General Hospital
Ma. Belen B. Pilit ; Ma. Cecille Añ ; onuevo-Cruz ; Cecilia A. Jimeno
Acta Medica Philippina 2024;58(Early Access 2024):1-8
Background and Objective:
Prolactinoma is the most common functioning tumor of the pituitary gland. While its clinical course and outcomes among different populations have been vastly described in the past, data of prolactinoma among Filipinos has not been explored. This paper aims to describe the clinical profile and outcome of prolactinoma among adult Filipino patients.
Methods:
We conducted a retrospective cohort study including 41 patients with prolactinoma seen at the Philippine General Hospital. The clinical profile, cranial imaging features, treatment modalities given, and their outcomes over a mean follow up of 16 months were evaluated.
Results:
The mean age at diagnosis was 36.76 ±13.99 years. Majority of our cohort were females. Macroprolactinoma were found in 75.61% and giant prolactinoma in 9.76%. The remaining 12.2% were mixed GH and PRL secreting tumors. Most common symptoms at presentation were blurring of vision, headache, and amenorrhea. Median PRL levels was 353 (200-470) ng/ml. Medical therapy with Bromocriptine was the primary treatment modality used in 78% of patients. We found no significant difference between patients who underwent surgical and medical primary treatment modalities in terms of outcomes. At the end of follow up, 82.6 % of patients achieved at least more than 50% reduction in their prolactin levels.
Conclusion
Overall, our study showed that adult Filipino patients with prolactinoma have a larger tumor size at diagnosis and a lower rate of improvement of gonadal function after treatment. There were no statistically significant differences in clinical and biochemical outcomes between the treatment modalities used.
Prolactinoma
;
Pituitary Neoplasms
;
Prolactin
Result Analysis
Print
Save
E-mail